Table 6.
Perspective | Drivers | Obstacles |
---|---|---|
Innovation-centric | D1 - Superior scientific understanding D2 - New applications D3 - Reduced cost and increased efficiency D4 - Scientific and technological advances D7 - Reduced animal use D10 - Accessibility of capabilities and resources |
O1 - Insufficient validation O2 - Complexity of interpretation O3 - Lack of standardization O9 - Uncertain economic benefits O10 - Inadequacy for some applications |
Adopter-centric | D5 - Belief in the potential of omics D6 - Stakeholder commitment and investment D8 - Numerous untested chemicals D9 - Enabling laws and regulations D11 - International collaboration & harmonization |
O4 - Lack of expertise O5 - Difficulty of coordination O6 - Resistance to change O7 - High level of required investment O8 - Lack of organizational support O11 - Concerns about litigation O12 - Frustrated expectations |